LAKEWOOD, N.J. 鈥� CareTria has acquired CaryHealth in a deal aimed at creating an integrated direct-to-patient pharmacy platform that combines therapy initiation, telehealth, AI-enabled patient engagement, and prescription fulfillment.
CareTria said the combined company will integrate provider and patient demand generation, digital onboarding, benefit investigation, telehealth services, and pharmacy dispensing into a single automated platform designed to improve therapy initiation and adherence.
The platform integrates CareTria鈥檚 therapy initiation and pharmacy fulfillment infrastructure with CaryHealth鈥檚 AI-powered digital pharmacy and patient engagement capabilities.
鈥淒irect-to-patient is a rapidly growing access channel in pharmacy. CareTria鈥檚 direct-to-patient platform has 90% prescription-to-therapy initiation conversion rates,鈥� said Willis Chandler, president and CEO of CareTria. 鈥淐aryHealth鈥檚 AI-enabled digital pharmacy infrastructure improves patient engagement and adherence, significantly strengthening the CareTria ecosystem that patients, providers, payors, and our biopharma partners rely on.鈥�
The companies said the combined platform includes automated benefit investigation capabilities, AI-enabled omnichannel patient engagement tools and multi-modal pharmacy dispensing across all 50 states, including direct-to-patient cash fulfillment, starter dose programs, free goods and commercial pharmacy services.
鈥淭he combination of CaryHealth鈥檚 AI-driven digital automation capabilities and CareTria鈥檚 robust pharmacy fulfillment infrastructure creates an industry-leading pharmacy partner for biopharma,鈥� said Areo Nazari, CEO of CaryHealth. 鈥淭ogether, we can help manufacturers deliver a more efficient, connected, and measurable patient experience across the full therapy journey.鈥�
CareTria is backed by Frazier Healthcare Partners, a healthcare-focused private equity firm headquartered in Seattle.
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release
